OR WAIT null SECS
August 28, 2020
In the study, GigaGen presents a novel technology for producing a new class of drug, recombinant hyperimmunes, that may potentially generate new COVID-19 therapies.
Thermo Fisher Scientific is increasing access to cry-electron microscopy with the help of contract research organizations.
August 07, 2020
The award will help a bioanalytics startup commercialize instrument technology for pharmaceutical antibody manufacturers.
August 05, 2020
The use of analytical assays is crucial for determining that biosimilar critical quality attributes remain on point.
August 03, 2020
The investment will allow for the expansion of analytical R&D efforts and will support the company’s reference materials business.
The company’s SLIM technology has been a part of the company’s accelerated growth by offering enhanced R&D analytics.
The company has launched a residual GMP-compliant test and dual sourcing opportunity designed to increase compliance and reduce risks for ATMP manufacture.
July 31, 2020
The company has begun development of a 3D bioreactor for the cGMP production of extracellular vesicle exosomes.
July 13, 2020
This method is expected to help bring gene therapies to market faster, safer, and cheaper.
July 09, 2020
The new SDMS automatically gathers and protects all instrument and other laboratory data as it is generated for enhanced lab management, quality, and security.